에 대한 최신 뉴스 FMC (NYSE:FMC) 주식

FMC CORP

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.

What Wedbush’s Dan Ives Said

Equities

News

Markets

DASH

ISRG

PLTR

S&amp;P 다우존스 인디시즈(S&amp;P Dow Jones Indices)는 금요일(7일)에 팔란티어 테크놀로지스(NASDAQ:PLTR)가 S&amp;P 100 지수에 합류한다고 발표했다. 데이터 분석 회사인 팔란티어의 주가는 선거 후 놀라운 상승세를 이어가고 있다.

팔란티어, 곧 S&amp;P 100 지수 합류...트럼프 당선 이후 주가 60% 급등

trader ai7

Large Cap

Mid Cap

Broad U.S. Equity ETFs

Politics

ETFs

FSLR

GILD

SMCI

VRSN

금융 시장은 도널드 트럼프 대통령의 2024년 11월 5일 선거와 후속 취임식 이후로 변동성을 보이고 있다. 새로운 행정부 하에서 어떤 회사들이 급등했고, 어떤 회사들이 어려움을 겪었는지 살펴보겠다. 최고 실적: Benzinga Pro의 데이터에 의하면, 2024년 11월 5일 이후로 SPDR S&amp;P 500 ETF Trust(NYSE:SPY)에 포함된 여섯 개 회사가 30% 이상 수익률을 기록했다고 한다. 

트럼프 당선 이후 S&amp;P 500 주식 중 최고와 최악의 수익률

Computer,Parts,Close,Up.,Computer,Chip.,Technology

Earnings

AMZN

ANET

ARKK

BABA

BEKE

INTC

MPLX

MSFT

ORCL

Citigourp Global Markets 2% Protected Notes Linked To The Djia

QCOM

UBER

최근 투자 전략의 변화로 데이비드 테퍼의 헤지펀드인 아팔루사(Appaloosa LP)가 포트폴리오에 상당한 변화를 주었다. 무슨 일이 발생했나: 이 회사의 최신 13F 보고서에 따르면, 반도체 보유량은 줄어들고, 오라클(NYSE:ORCL)와 ARK 혁신 ETF(ARKK)를 포함한 다른 기술 주식에 대한 지분은 증가했다.

데이비드 테퍼의 헤지펀드 아팔루사, 포트폴리오 개편 및 반도체 주식 축소

FMC Corp

FRMRS&MER BNCORP LODI CA by Farmers & Merchants Bancorp

Farmers & Merchants Bancorp

Federal Home Loan Mortgage Corp

Northern Lights Fund Trust IV FM Compounders Equity ETF

FRESENIUS MED CARE AG ORD by Fresenius Medical Care AG

Fresenius Medical Care AG

FM Focus Equity ETF

FORAN MINING CORP by Foran Mining Corporation

Foran Mining Corp

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
<h3 class="wp-block-heading">Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 8.55%</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained an Overweight rating and slashed the price target from $22 to $20 on May 5, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Wells Fargo analyst Michael Sison downgraded the stock from Overweight to Equal-Weight and lowered the price target from $17 to $13 on May 5, 2025. This analyst has an accuracy rate of 64%.</li>
<li>Recent News: On May 28, Huntsman announced that it has completed the strategic review of its European Maleic Anhydride business.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528">latest HUN news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528"><img loading="lazy" decoding="async" width="906" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070822/image-353.png" alt="" class="wp-image-929655" style="width:634px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070822/image-353.png 906w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070822/image-353-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070822/image-353-768x710.png 768w" sizes="(max-width: 906px) 100vw, 906px" /></a></figure>
<h3 class="wp-block-heading">FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 5.95%</li>
<li>Keybanc analyst Aleksey Yefremov maintained an Overweight rating and raised the price target from $49 to $53 on May 2, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Seaport Global analyst Michael Harrison maintained a Buy rating and cut the price target from $72 to $55 on March 5, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On April 30, FMC issued second-quarter adjusted EPS guidance below estimates.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest FMC <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528"><img loading="lazy" decoding="async" width="920" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070859/image-354.png" alt="" class="wp-image-929656" style="width:604px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070859/image-354.png 920w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070859/image-354-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070859/image-354-768x707.png 768w" sizes="(max-width: 920px) 100vw, 920px" /></a></figure>
<h3 class="wp-block-heading">The Chemours Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 3.30%</li>
<li>Morgan Stanley analyst Vincent Andrews maintained an Equal-Weight rating and cut the price target from $22 to $15 on May 12, 2025. This analyst has an accuracy rate of 78%.</li>
<li>Mizuho analyst John Roberts upgraded the stock from Neutral to Outperform with a price target of $19 on March 27, 2025. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On May 6, Chemours reported worse-than-expected first-quarter adjusted EPS results.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528">latest CC news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528"><img loading="lazy" decoding="async" width="908" height="815" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070926/image-355.png" alt="" class="wp-image-929658" style="width:580px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070926/image-355.png 908w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070926/image-355-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070926/image-355-768x689.png 768w" sizes="(max-width: 908px) 100vw, 908px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45616471/jim-cramer-says-rocket-is-a-very-fine-company-recommends-buying-this-health-care-stock">Jim Cramer Says Rocket Is A &#8216;Very Fine&#8217; Company, Recommends Buying This Health Care Stock</a> </li>
</ul>
Photo via Shutterstock

Dividends

Price Target

Pre-Market Outlook

Analyst Ratings

Trading Ideas

Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
<h3 class="wp-block-heading">Tronox Holdings plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 9.77%</li>
<li>BMO Capital analyst John McNulty downgraded the stock from Outperform to Market Perform and cut the price target from $13 to $7 on May 7, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Morgan Stanley analyst Vincent Andrews maintained an Equal-Weight rating and slashed the price target from $12 to $8 on May 5, 2024. This analyst has an accuracy rate of 79%.</li>
<li>Recent News: On April 30, Tronox Holdings posted first-quarter adjusted loss of 15 cents per share.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest TROX <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509"><img loading="lazy" decoding="async" width="908" height="815" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09050938/image-100.png" alt="" class="wp-image-909780" style="width:628px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09050938/image-100.png 908w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09050938/image-100-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09050938/image-100-768x689.png 768w" sizes="(max-width: 908px) 100vw, 908px" /></a></figure>
<h3 class="wp-block-heading">Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 8.32%</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained an Overweight rating and cut the price target from $22 to $20 on May 5, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Wells Fargo analyst Michael Sison downgraded the stock from Overweight to Equal-Weight and slashed the price target from $17 to $13 on May 5, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Recent News: On May 1, Huntsman reported in-line loss for the first quarter.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest HUN <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509"><img loading="lazy" decoding="async" width="911" height="823" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051009/image-101.png" alt="" class="wp-image-909782" style="width:559px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051009/image-101.png 911w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051009/image-101-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051009/image-101-768x694.png 768w" sizes="(max-width: 911px) 100vw, 911px" /></a></figure>
<h3 class="wp-block-heading">FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 6.34%</li>
<li>Keybanc analyst Aleksey Yefremov maintained an Overweight rating and raised the price target from $49 to $53 on May 2, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Seaport Global analyst Michael Harrison maintained a Buy rating and cut the price target from $72 to $55 on March 5, 2025. This analyst has an accuracy rate of 64%.</li>
<li>Recent News: On April 30, FMC issued second-quarter adjusted EPS guidance below estimates.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest FMC <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509"><img loading="lazy" decoding="async" width="912" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051041/image-102.png" alt="" class="wp-image-909783" style="width:560px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051041/image-102.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051041/image-102-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051041/image-102-768x701.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45285413/top-3-financial-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Financial Stocks Which Could Rescue Your Portfolio This Month</a> </li>
</ul>
Photo via Shutterstock

TROX

Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks With Over 6% Dividend Yields

Keybanc analyst Aleksey Yefremov maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Overweight and raises the price target from $49 to $53.

Keybanc Maintains Overweight on FMC, Raises Price Target to $53

Throughout the last three months, 12 analysts have evaluated FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $47.08, a high estimate of $55.00, and a low estimate of $38.00. This current average represents a 21.65% decrease from the previous average price target of $60.09. 
<img src="https://www.benzinga.com/files/images/story/2025/1746133212_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of FMC's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$41.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Richard Garchitorena</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$41.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$49.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Duffy Fischer</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$51.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Harrison</td>
<td>Seaport Global</td>
<td>Lowers</td>
<td>Buy</td>
<td>$55.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$51.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$48.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$38.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$48.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Joel Jackson</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$50.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Vincent Andrews</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$46.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$47.00</td>
<td>$78.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to FMC. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of FMC's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of FMC's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on FMC analyst ratings.</a>
<h2>About FMC</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>FMC's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: FMC's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 6.82%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: FMC's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -1.37% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): FMC's ROE excels beyond industry benchmarks, reaching -0.37%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): FMC's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.14% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 0.78, FMC faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying FMC: Insights From 12 Analyst Reviews

WIIM

FMC shares are trading lower after the company issued Q2 adjusted EPS guidance below estimates.

UBS analyst Joshua Spector maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral and raises the price target from $38 to $41.

UBS Maintains Neutral on FMC, Raises Price Target to $41

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) affirms FY2025 Adj EPS guidance from $3.26-$3.70 to $3.26-$3.70 vs $3.41 analyst estimate. Affirms FY2025 sales outlook from $4.15 billion-$4.35 billion to $4.15 billion-$4.35 billion vs $4.19 billion estimate.

Guidance

FMC Affirms FY2025 Adj EPS Guidance of $3.26-$3.70 vs $3.41 Est; Affirms FY2025 Sales Guidance of $4.15B-$4.35B vs $4.19B Est

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) is looking for Q2 Adj EPS of $0.52-$0.68 vs $0.75 analyst estimate. sees sales of $940.000 million-$1.100 billion vs $1.03 billion analyst estimate.

FMC Sees Q2 Adj EPS $0.52-$0.68 vs $0.75 Est; Sees Sales $940.000M-$1.100B vs $1.03B Est

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.09 by 100 percent. This is a 50 percent decrease over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $791.40 million which beat the analyst consensus estimate of $784.05 million by 0.94 percent. This is a 13.79 percent decrease over sales of $918.00 million the same period last year.

Earnings Beats

FMC Q1 Adj. EPS $0.18 Beats $0.09 Estimate, Sales $791.40M Beat $784.05M Estimate

AEIS

ALGN

ALKT

AMCR

ANSS

ARAY

ATNI

AWRE

BLCO

BLFY

BLKB

BXMT

CACC

CAKE

CDNA

CFLT

CGNX

CHEF

CHRW

CLMB

CMPR

CNMD

CNXN

COCO

COKE

CPSH

CSLR

CSTM

CTOS

CTSH

CVEO

CWAN

CWEN

DFIN

EBAY

ENVX

EQIX

EQNR

ETSY

EXTR

FCPT

FFWM

FINW

FMBH

FORM

FTAI

GEHC

GKOS

GNRC

GRBK

GRMN

GTES

Earnings Scheduled For April 30, 2025

Wells Fargo analyst Richard Garchitorena maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Equal-Weight and lowers the price target from $43 to $41.

Wells Fargo Maintains Equal-Weight on FMC, Lowers Price Target to $41

Peru approves Keenali&#x2122; herbicide, transforming rice weed management in high-growth Latin American market&nbsp;
FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>), a leading global agricultural sciences company, today announced it has received regulatory approval for Keenali&#x2122; herbicide powered by Dodhylex&#x2122; active (tetflupyrolimet) in Peru. The approval represents the first active ingredient and commercial product registration globally for this breakthrough herbicide technology. Dodhylex&#x2122; active is the first and only herbicide classified by the Herbicide Resistance Action Committee (HRAC) and the Weed Science Society of America (WSSA) as a Group 28 herbicide.

FMC Gets Regulatory Approval For Keenali Herbicide Powered By Dodhylex Active In Peru

In the preceding three months, 12 analysts have released ratings for FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>), presenting a wide array of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for FMC, revealing an average target of $50.75, a high estimate of $65.00, and a low estimate of $38.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 20.25%. 
<img src="https://www.benzinga.com/files/images/story/2025/1744668042_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of FMC by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Aleksey Yefremov &#x7C;Keybanc &#x7C;Lowers &#x7C;Overweight &#x7C; $49.00&#x7C;$51.00 &#x7C; 
&#x7C;Duffy Fischer &#x7C;Goldman Sachs &#x7C;Announces &#x7C;Buy &#x7C; $51.00&#x7C;- &#x7C; 
&#x7C;Michael Harrison &#x7C;Seaport Global &#x7C;Lowers &#x7C;Buy &#x7C; $55.00&#x7C;$72.00 &#x7C; 
&#x7C;Aleksey Yefremov &#x7C;Keybanc &#x7C;Lowers &#x7C;Overweight &#x7C; $51.00&#x7C;$55.00 &#x7C; 
&#x7C;Benjamin Theurer &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $48.00&#x7C;$65.00 &#x7C; 
&#x7C;Joshua Spector &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $38.00&#x7C;$66.00 &#x7C; 
&#x7C;Steve Byrne &#x7C;B of A Securities &#x7C;Lowers &#x7C;Underperform &#x7C; $48.00&#x7C;$61.00 &#x7C; 
&#x7C;Joel Jackson &#x7C;BMO Capital &#x7C;Lowers &#x7C;Market Perform &#x7C; $50.00&#x7C;$62.00 &#x7C; 
&#x7C;Vincent Andrews &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $46.00&#x7C;$70.00 &#x7C; 
&#x7C;Arun Viswanathan &#x7C;RBC Capital &#x7C;Lowers &#x7C;Sector Perform &#x7C; $47.00&#x7C;$78.00 &#x7C; 
&#x7C;Patrick Cunningham &#x7C;Citigroup &#x7C;Raises &#x7C;Neutral &#x7C; $61.00&#x7C;$55.00 &#x7C; 
&#x7C;Benjamin Theurer &#x7C;Barclays &#x7C;Maintains &#x7C;Overweight &#x7C; $65.00&#x7C;$65.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to FMC. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of FMC's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into FMC's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on FMC analyst ratings.</a>
<h2>Delving into FMC's Background</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>FMC's Economic Impact: An Analysis</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: FMC's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 6.82%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -1.37%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): FMC's ROE stands out, surpassing industry averages. With an impressive ROE of -0.37%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): FMC's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.14% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 0.78, FMC faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

12 Analysts Have This To Say About FMC

Keybanc analyst Aleksey Yefremov maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Overweight and lowers the price target from $51 to $49.

Keybanc Maintains Overweight on FMC, Lowers Price Target to $49

FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>), a leading agricultural sciences company, today announced it has received registration in Brazil for&nbsp;Sofero&#x2122; Fall pheromone targeting fall armyworm (Spodoptera frugiperda). Sofero&#x2122; Fall is the first in the company's lineup of distinctive pheromone products for row crops offering growers a novel approach to sustainably control pests, manage resistance and boost productivity.
"The registration of&nbsp;Sofero&#x2122; Fall in Brazil marks a significant milestone in our efforts to bring high-performance, sustainable crop protection solutions to growers," said Ronaldo Pereira, FMC president. "We are excited to provide growers with a powerful new tool in the battle against fall armyworm. Fall armyworm has developed resistance to many traditional insecticides, and growers are seeking alternative solutions to complement their existing practices. Sofero&#x2122; Fall offers an efficient and sustainable way to overcome mounting resistance challenges and enhance the performance of their pest management programs."
Sofero&#x2122; Fall features an innovative mode of action based on mating disruption. This breakthrough technology harnesses the powerful signals of pheromones to naturally disrupt the mating cycles of fall armyworm, preventing it from reproducing. By breaking the pest cycle before the next generation can emerge, Sofero&#x2122; Fall protects crops in the early stages of development, reducing damage and supporting healthy growth. The unique, sprayable formulation leverages FMC's proprietary microencapsulation technology to improve stability and extend its effectiveness, optimizing performance and providing growers with longer-lasting protection.
Sofero&#x2122; Fall is the first product to launch under FMC's global Sofero&#x2122; pheromone solutions brand. The Sofero&#x2122; portfolio of products will target destructive pests in key crops including rice, corn, cotton and soybeans. Sofero&#x2122; pheromone solutions are designed to be used as part of an integrated program, combined with synthetics, biologicals and precision technologies to improve operational efficiency.
"Sofero&#x2122; pheromone solutions inspire a new way to think about crop protection – one that is focused on prevention over treatment," continued Pereira. "With our extensive portfolio and global reach, FMC is uniquely positioned to bring these game-changing solutions to growers around the world, creating a more sustainable future for agriculture while solving real problems in the field."
Registration for Sofero&#x2122; Frugi pheromone, which also targets fall armyworm, is pending in Mexico and anticipated in 2027.

FMC Corporation Receives First Product Registration In Brazil For Its Sofero Fall Pheromone

AXTA

Shares of companies in the broader chemicals sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

Biotech

General

FMC And Bayer Collaborate To Bring Isoflex Active Herbicide Technology To European Markets

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer recommended buying Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>).
As per recent news, Splitit announced the launch of its new, fully embedded Shopify App, Splitit Card Installments, on Tuesday<a href="https://www.benzinga.com/quote/SHOP">.</a>
Cramer said Plains All American Pipeline, L.P. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NASDAQ">PAA</a>) is a &#8220;terrific&#8221; stock.
Morgan Stanley analyst Robert Kad raised the price target on the stock from $19 to $23 on Tuesday, supporting his view.
Cramer recommended selling SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>). &#8220;I regard SoundHound as a complete meme stock,&#8221; he added.
On Tuesday, SoundHound AI named Shawnna DelHierro as Senior Vice President and Chief Information Officer.
The Mad Money host recommended avoiding FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>).
On the earnings front, FMC Corporation is scheduled to release its first quarter 2025 earnings on Wednesday, April 30, 2025, after the closing bell.
When asked about Core Natural Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNR#NYSE">CNR</a>), &#8220;There's just not much to these stocks. I wish they could find a bottom, but they can't.&#8221;
According to the recent earnings report, Core Natural Resources reported quarterly earnings of $1.04 per share on Feb. 20, which missed the analyst consensus estimate of $3.09 per share. The company reported quarterly sales of $595.291 million, which beat the analyst consensus estimate of $553.850 million.
Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) is a &#8220;winner,&#8221; Cramer said.
On Tuesday, Everfox disclosed a strategic partnership with Palantir to enhance joint command and control capabilities.
Cramer said, &#8220;You can own Rocket (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>).&#8221;
On March 10, Rocket Companies agreed to acquire Redfin Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>), a digital real estate platform, in an all-stock transaction valued at $12.50 per share, or approximately $1.75 billion in equity.
Price Action:
<ul>
<li>Shopify shares gained 0.5% to settle at $109.82 on Tuesday.</li>
<li>Plains All American Pipeline shares gained 0.1% to close at $20.18 during the session.</li>
<li>SoundHound shares fell 1.1% to settle at $10.20.</li>
<li>FMC shares fell 1.3% to close at $41.20.</li>
<li>Rocket Companies&#8217; shares fell 2.8% to close at $13.38  on Tuesday.</li>
<li>Core Natural Resources shares rose 2% to settle at $76.25 on Tuesday.</li>
<li>Palantir shares fell 0.3% to close at $96.50.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44471817/top-2-health-care-stocks-that-are-ticking-portfolio-bombs-3">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>
Photo: Shutterstock

Media

RDFN

SHOP

SOUN

Jim Cramer: Palantir Is A 'Winner,' Recommends Selling This Tech Stock

Goldman Sachs analyst Duffy Fischer initiated coverage on several major U.S. agriculture input <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color" rel="noreferrer noopener">stocks, citing several factors</a>.
The analyst writes that they believe the agricultural macro environment is still stabilizing after the peak caused by the Russia-Ukraine war.
Fischer says that while Spring 2025 looks better than expected (excluding FX) thanks to expected higher corn acreage and a short Fall application window, they anticipate a continued drift toward normalized levels later this year.
CTVA: The analyst initiated coverage on Corteva, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) with a Buy <a target="_blank" href="https://www.benzinga.com/quote/ctva/analyst-ratings" rel="noreferrer noopener">and price forecast of $71</a>.
The analyst highlights the company&#8217;s strong seed and crop protection business, which is poised to benefit from significant cost tailwinds in 2025.
The analyst notes that the business is more focused on R&amp;D compared to crop protection, which gives it substantial pricing power, enabling it to maintain strong pricing even during down-cycles.
FMC: Fischer initiated coverage on FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Buy rating <a target="_blank" href="https://www.benzinga.com/quote/fmc/analyst-ratings" rel="noreferrer noopener">and price forecast of $51</a>.
The analyst notes that the company is the only pure-play crop protection firm in the group.
The post-patent strategy for Rynaxypyr holds promise, and its R&amp;D pipeline is expected to yield dividend by 2027+, adds the analyst.
Additionally, the analyst notes the market is undervaluing the potential growth from new product launches in 2026/27 and beyond, as current consensus estimates are below FMC&#8217;s 2027 guidance targets.
MOS: The analyst started coverage on Mosaic Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>) with a Buy rating <a target="_blank" href="https://www.benzinga.com/quote/mos/analyst-ratings" rel="noreferrer noopener">and price forecast of $31</a>.
The analyst writes that the major reason for favoring the stock is that phosphate has the most favorable supply-demand outlook heading into 2025, with limited capacity growth and rising demand from farmers and LFP EV batteries.
If the company can avoid production disruptions, it can improve capacity utilization, boosting margins during a period of strong phosphate stripping margins, adds the analyst.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/25/03/44304280/baker-hughes-novalt-gas-turbines-to-power-data-centers-amid-growing-ai-demand" target="_blank" rel="noreferrer noopener">Baker Hughes&#8217; NovaLT Gas Turbines To Power Data Centers Amid Growing AI Demand</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Initiation

CTVA

Goldman Sachs Agri Stock Picks: Corteva's R&D Edge, FMC's Pipeline, And Mosaic's Phosphate Advantage Set Up Strong Growth

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Baird analyst Ben Kallo initiated coverage on Ormat Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORA#NYSE">ORA</a>) with a Neutral rating and announced a price target of $81. Ormat Technologies shares closed at $71.10 on Wednesday. <a href="https://www.benzinga.com/quote/ora/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Goldman Sachs analyst Duffy Fischer initiated coverage on FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Buy rating and announced a price target of $51. FMC shares closed at $39.84 on Wednesday. <a href="https://www.benzinga.com/quote/FMC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keefe, Bruyette &amp; Woods analyst MarK Shutley initiated coverage on Eagle Financial Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFSI#NASDAQ">EFSI</a>) with an Outperform rating and announced a price target of $40. Eagle Financial shares closed at $32.43 on Wednesday. <a href="https://www.benzinga.com/quote/EFSI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Truist Securities analyst Lucas Servera initiated coverage on FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) with a Buy rating and announced a price target of $305. FedEx shares closed at $243.51 on Wednesday. <a href="https://www.benzinga.com/quote/FDX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Truist Securities analyst Lucas Servera initiated coverage on United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) with a Buy rating and announced a price target of $140. UPS shares closed at $115.26 on Wednesday. <a href="https://www.benzinga.com/quote/UPS/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying FDX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="590" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13080014/image-100-1024x590.png" alt="" class="wp-image-822773" style="width:571px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13080014/image-100-1024x590.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13080014/image-100-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13080014/image-100-768x443.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13080014/image-100.png 1112w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44295828/adobe-intel-and-3-stocks-to-watch-heading-into-thursday">Adobe, Intel And 3 Stocks To Watch Heading Into Thursday</a></li>
</ul>

EFSI

This FedEx Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Press Releases

FMC Deadline: FMC Purchasers Have Opportunity to Lead FMC Corporation Securities Fraud Lawsuit

Legal

FMC Corporation Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights – FMC

Commodities

FMC Corporation secures first global registration for agricultural breakthrough, Dodhylex™ active

FMC ALERT: Bragar Eagel & Squire, P.C. is Investigating FMC Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

FMC Corporation names Sara Velazquez Ponessa as new general counsel

FMC Corporation announces election of Steven Merkt to Board of Directors

FMC Corporation Declares Quarterly Dividend

FMC Corporation delivers first quarter results at higher end of guidance range, reaffirms full-year outlook

FMC Corporation demonstrates climate-smart, business-forward approach to sustainability

Kuehn Law Encourages Investors of FMC Corporation to Contact Law Firm

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions

CF Industries Holdings, Inc. Common Stock

CF Industries Holdings

Corteva

Enlightify

Brazil Potash

Intrepid Potash

Mosaic

N2OFF

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

CVR Partners, LP Common Units representing Limited Partner Interests

CVR Partners

Keybanc

Wells Fargo

Goldman Sachs

Seaport Global

S&amp;P 다우존스 인디시즈(S&amp;P Dow Jones Indices)는 금요일(7일)에 팔란티어 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>)가 S&amp;P 100 지수에 합류한다고 발표했다. 데이터 분석 회사인 팔란티어의 주가는 선거 후 놀라운 상승세를 이어가고 있다.
무슨 일 있었나: 팔란티어는 &#8220;S&amp;P 100에 편입된 것을 자랑스럽게 생각한다&#8221;고 일요일(9일)에 밝혔다.
덴버에 본사를 둔 팔란티어는 분기별 리밸런싱에 맞춰 3월 24일부터 다우(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)를 대체할 예정이다. 인튜이티브 서지컬(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>)과 서비스나우(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>)도 S&amp;P 100 지수에 편입되며, 이들은 크래프트 하인즈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>)와 포드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>)를 대체한다.
팔란티어는 도널드 트럼프 대통령의 11월 대선 승리 이후 60% 가까이 급등한 84.82달러를 기록하며 S&amp;P 500 주식 중 최고 수익률을 나타냈다. 팔란티어의 지난 1년간 주가 상승률은 무려 234.95%에 이른다.
시장 애널리스트들은 팔란티어의 급격한 상승을 인공지능(AI) 역량과 알렉스 카프 CEO의 <a href="https://www.benzinga.com/news/large-cap/25/03/44202991/best-and-worst-performing-sp-500-stocks-since-trumps-election-win" target="_blank" rel="noopener">정부 효율성 이니셔티브</a>에 대한 지원 덕분으로 보고 있다.
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Palantir is proud to be admitted into the S&amp;P 100.
Onwards. <a href="https://t.co/WxwfObpIUG">pic.twitter.com/WxwfObpIUG</a>
&mdash; Palantir (@PalantirTech) <a href="https://twitter.com/PalantirTech/status/1898888631944630768?ref_src=twsrc%5Etfw">March 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
왜 중요한가: 최근 애널리스트들의 평가는 엇갈린 전망을 제시하고 있다. 25명의 애널리스트가 제시한 <a href="https://www.benzinga.com/quote/PLTR/analyst-ratings" target="_blank" rel="noopener">목표주가 컨센서스</a>는 70.30달러인 반면, 웨드부시 루프 캐피탈, 씨티그룹의 가장 최근 평가는 평균 123.67달러로 약 46%의 잠재적 상승 여력이 있음을 시사한다.
또한 S&amp;P 지수의 다른 중요한 변화로는 도어대시(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>)가 S&amp;P 500에 포함되고, FMC(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>)와 셀라니즈 코퍼레이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>)은 트럼프 선거 이후 최악의 실적을 기록한 주식 중 하나로 S&amp;P SmallCap 600 지수로 이동된다.
주가 움직임: 팔란티어는 금요일에 5.52% 상승한 84.90달러로 마감한 후 시간외 거래에서 0.09% 하락한 84.82달러로 마감했다. 현재까지 주가는 12.93% 상승했으며, 지난 1년 동안 234.95% 급등했다. 팔란티어 주가는 2월 18일에 기록한 사상 최고가인 124.62달러 대비 38% 하락한 상태다.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter">
<div class="wp-block-embed__wrapper"></div>
</figure>
이미지 출처: Shutterstock
면책 조항: 이 콘텐츠는 부분적으로 AI 도구의 도움을 받아 생성되었으며, Benzinga 편집자가 검토하고 게시했습니다.
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

팔란티어, 곧 S&P 100 지수 합류...트럼프 당선 이후 주가 60% 급등

금융 시장은 도널드 트럼프 대통령의 <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election" target="_blank" rel="noopener" data-google-interstitial="false">2024년 11월 5일 선거</a>와 후속 취임식 이후로 변동성을 보이고 있다. 새로운 행정부 하에서 어떤 회사들이 급등했고, 어떤 회사들이 어려움을 겪었는지 살펴보겠다.
최고 실적: <a href="https://pro.benzinga.com/dashboard">Benzinga Pro의 데이터</a>에 의하면, 2024년 11월 5일 이후로 SPDR S&amp;P 500 ETF Trust(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)에 포함된 여섯 개 회사가 30% 이상 수익률을 기록했다고 한다.
팔란티어 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>)가 59.91% 상승하여 51.13달러에서 81.76달러로 급등하며 1위에 올랐다. 덴버, 콜로라도에 본사를 둔 이 회사는 연간 184% 이상의 수익률을 기록하고 있다. 소매 투자자들 사이에서 인기를 끌고 있는 팔란티어는 인공지능(AI) 트렌드를 활용하고 CEO 알렉스 카프가 일론 머스크의 정부 효율성 노력을 지지한 것을 통해 큰 주목을 받았다. 그는 이를 <a href="https://www.benzinga.com/markets/equities/25/02/43806845/palantir-ceo-alex-karp-backs-elon-musks-government-efficiency-efforts-calls-him-most-important-builder">사기, 낭비 및 남용을 없애려는 추진력</a>으로 방어했다.
벤징가 엣지에 따르면, 팔란티어는 100점 만점에 99점이라는 매우 높은 점수를 받아 모멘텀에서 유리한 위치에 있지만, 주요 가치 평가 지표에서는 뒤처져 있어 주식이 과대평가될 수 있음을 나타낸다.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/pltr"><img loading="lazy" decoding="async" class="wp-image-814893" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/07132016/Screenshot-2025-03-07-at-1.20.11-PM-1024x232.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/07132016/Screenshot-2025-03-07-at-1.20.11-PM-1024x232.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/07132016/Screenshot-2025-03-07-at-1.20.11-PM-300x68.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/07132016/Screenshot-2025-03-07-at-1.20.11-PM-768x174.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/07132016/Screenshot-2025-03-07-at-1.20.11-PM.png 1340w" alt="" width="1024" height="232" /></a></figure>
<ul>
<li>나머지 BZ 엣지 순위를 잠금 해제하고 <a href="https://www.benzinga.com/quote/TPR">태피스트리와의 비교를 확인하세요</a></li>
</ul>
트럼프의 선거 승리 이후 30% 이상 수익률을 기록한 다른 다섯 개 주식은 다음과 같다:
<ul>
<li>태피스트(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>), 49.66% 상승 (연환산 148.56%).</li>
<li>워너 브라더스 디스커버리(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>), 35.32% 상승 (연환산 105.68%).</li>
<li>베리사인(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>), 33.19% 상승 (연환산 99.30%).</li>
<li>슈퍼 마이크로 컴퓨터(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), 33.32% 상승 (연환산 99.69%).</li>
<li>길리어드 사이언스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>), 30.48% 상승 (연환산 91.19%).</li>
</ul>
최악의 실적: 트럼프가 11월 선거에서 승리한 이후 S&amp;P 500에 포함된 여러 회사들은 훨씬 더 나쁜 실적을 보였다.
일부 저조한 실적을 보인 회사들은 트럼프의 정책에 영향을 받았다. 퍼스트 솔라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>)는 태양광 패널 제조업체로, 트럼프가 화석 연료를 지원하는 것에 대한 우려로 주가가 36.41% 하락했다. 이 회사의 주가는 2024년 11월 5일 이후로 36.41% 하락했다.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/FSLR"><img loading="lazy" decoding="async" class="wp-image-814924" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/07133556/Screenshot-2025-03-07-at-1.35.52-PM-1024x230.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/07133556/Screenshot-2025-03-07-at-1.35.52-PM-1024x230.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/07133556/Screenshot-2025-03-07-at-1.35.52-PM-300x67.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/07133556/Screenshot-2025-03-07-at-1.35.52-PM-768x173.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/07133556/Screenshot-2025-03-07-at-1.35.52-PM.png 1316w" alt="" width="1024" height="230" /></a></figure>
벤징가 엣지에 따르면, 회사는 저평가된 가치에도 불구하고 모멘텀과 성장 전망이 좋지 않아 성과가 좋지 않다고 한다.
트럼프의 승리 이후 S&amp;P 500에서 최악의 실적을 기록한 네 개의 주식은 다음과 같다:
<ul>
<li>아이언 마운틴(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRM#NYSE">IRM</a>) 주식은 34.47% 하락했다.</li>
<li>온 세미컨덕터(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) 주식은 35.71% 하락했다.</li>
<li>FMC 코퍼레이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) 주식은 35.32% 하락했다.</li>
<li>셀라니즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) 주식은 39.6% 하락했다.</li>
</ul>
추가 읽기:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44194357/markets-breathe-sigh-of-relief-as-february-jobs-data-shows-economy-not-falling-off-a-cliff-economist-says">2월 고용 데이터가 경제가 &#8216;벼랑 끝에서 떨어지지 않는다&#8217;고 보여주자 시장이 &#8216;안도감&#8217;을 표했습니다. 경제학자 발언</a></li>
</ul>
면책 조항: 작성자는 발행 시점에 Warner Bros. Discovery의 주식을 보유하고 있습니다.
이미지는 Midjourney를 통해 인공지능으로 생성되었습니다.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

트럼프 당선 이후 S&P 500 주식 중 최고와 최악의 수익률

최근 투자 전략의 변화로 데이비드 테퍼의 헤지펀드인 아팔루사(Appaloosa LP)가 포트폴리오에 상당한 변화를 주었다.
무슨 일이 발생했나: 이 회사의 최신 13F 보고서에 따르면, 반도체 보유량은 줄어들고, 오라클(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>)와 ARK 혁신 ETF(ARKK)를 포함한 다른 기술 주식에 대한 지분은 증가했다.
아팔루사는 2023년 4분기에 약 1억 4,000만 달러 상당의 오라클 주식 130만 주를 매수하고, ARK 혁신 ETF에 대해 거의 1억 3,300만 달러 가치의 콜 옵션을 매수했다. 이 헤지펀드는 또한 FMC 코퍼레이션(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>)과 제너럴 모터스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>)에 대한 새로운 포지션을 설정했다.
또한 주택 개조, 건설 및 건축 자재 부문에도 투자하여 마스코(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>), 모호크 인더스트리스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) 및 오웬스 코닝(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>)과 같은 회사들의 주식을 매입했다.
인베스토피디아(Investopedia)의 보도에 따르면, 아팔루사는 어드밴스드 마이크로 디바이시스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), 알파벳 클래스 C 주식(GOOG), 퀄(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), 우버 테크놀로지스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) 및 타이완 반도체 제조(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>)와 같은 몇몇 기술 회사들에 대한 보유량을 줄였다. 가장 큰 매각은 인텔(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>)의 주식 약 170만 주를 포함한다.
또한 기술 주식을 제외하고, 이 펀드는 KE 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>), 메이시스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) 및 PDD 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>)의 주식을 매각했다. 반면, 아팔루사는 시저스 엔터테인먼트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>), MPLX LP(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLX#NYSE">MPLX</a>), 알리바바 그룹 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), 아마존(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) 및 마이크로소프트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)에 대한 기존 포지션을 추가했다.
헤지펀드는 또한 4분기에 아리스타 네트웍스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>)와 엔터프라이즈 프로덕트 파트너스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>)의 두 포지션을 완전히 매각했다.
중요한 이유: 아팔루사의 포트폴리오 재편성은 다각화로의 전략적 전환을 나타낸다. 반도체 보유량의 감소는 글로벌 칩 부족 상황 속에서 발생한 일로, 조심스러운 접근 방식을 나타낼 수 있다.
기타 기술 주식과 주택 개조 부문에서의 지분 증가 역시 팬데믹 동안 회복력을 보인 산업에 대한 집중을 시사한다. FMC 코퍼레이션과 제너럴 모터스에 대한 새 포지션은 각각 농약 및 자동차 산업에 대한 베팅을 나타낸다.
반면, 매각은 특정 주식이나 섹션과 관련된 위험을 완화하려는 시도를 반영할 수 있다.
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/earnings-beats/25/02/43740996/palo-alto-analysts-optimistic-on-revenue-growth-expanding-market-share" target="_blank" rel="noreferrer noopener">팔로알토 분석가들, 매출 성장 및 시장 점유율 확대에 대해 낙관적</a></li>
</ul>
이미지: Shutterstock


Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

최근 일로, 테슬라(NASDAQ:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/tsla" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for TSLA">TSLA</a>)의 주식이 대폭 급락한 반면 S&amp;P 500 지수의 여섯 개 주식들은 급등했다.
어떤 일이 있었나 (What Happened): 테슬라 주식이 하락하면 S&amp;P 500 지수 6개 주식은 상승하는 경향이 있다고 CNBC Pro가 월요일 <a href="https://www.cnbc.com/2024/04/23/when-tesla-shares-fall-these-6-stocks-tend-to-rise-according-to-recent-history.html">보도</a>했다. 이 중에는 린데(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIN#NASDAQ">LIN</a>), FMC(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>), 이베이(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>), 처치 앤 드와이트(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHD#NYSE">CHD</a>), 월마트(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) 및 웰스 파고(Wells Fargo) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>)가 포함되어 있다. 지난 한 달동안 이러한 주식들은 테슬라의 성과와 반대되는 상관관계를 보였다. 올해 테슬라 주식의 40% 하락과는 대조적으로 이 6개 주식은 일반적으로 상승했다.
도이체 방크의 분석가 엠마누엘 로스너(Emmanuel Rosner)는 테슬라가 새로운 저가형 차량에서 자율주행 기술로 초점을 전환함에 따라 테슬라의 어려운 상황이 지속될 수 있다고 예측한다. 로스너는 최근 테슬라 주식의 목표 가격을 189달러에서 123달러로 낮추었는데, 이는 내년에 약 15%의 하락 가능성을 나타낸다.
그러나 이 주식들의 테슬라와의 상반된 움직임이 인과 관계나 미래 수익, 가격 행동 패턴을 보장한다는 의미는 아니다. 처치 앤 드와이트는 지난 3월과 지난주에 테슬라와의 상반된 상관관계를 보인 유일한 주식이다.
왜 중요한가 (Why It Matters): 이러한 주가 성과의 변화는 테슬라의 최근 결정으로 인해 발생한다. 이 회사는 최근 미국 마케팅 팀을 해고했으며 최고경영자(CEO) 일론 머스크는 팀의 광고가 &#8216;너무 일반적&#8217;이라고 <a href="https://www.benzinga.com/news/24/04/38370123/elon-musk-admits-tesla-ads-were-far-too-generic-after-laying-off-us-marketing-team-couldve-been-any">설명했다</a>. 이번 조치는 전사적 10% 정리해고의 일환이었다.
또한 테슬라는 완전 자율주행(FSD) 운전자 지원 소프트웨어의 가격을 대폭 인하했다. 1년도 채 되지 않아 머스크는 FSD의 <a href="https://www.benzinga.com/news/24/04/38351810/tesla-fsd-is-now-nearly-50-cheaper-than-when-elon-musk-called-it-very-low-just-under-a-year-ago" target="_blank" rel="noopener">15,000</a>달러를 저렴한 가격으로 간주했다. 그러나 그 가격은 약 50% 인하됐다. 이러한 가격 인하는 회사가 자율주행 기술에 초점을 맞추는 요인이 될 수 있다.

TSLA

테슬라 주가 하락 시, 이베이 및 월마트를 포함한 6개의 S&P 500 종목은 종종 상승

Comments

FMC

뉴스

에 대한 최신 뉴스 FMC (NYSE:FMC) 주식

월요일, 3월 10, 2025

금요일, 3월 07, 2025

일요일, 2월 16, 2025

화요일, 4월 23, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌